Chinese COVID-19 Vaccine Exhibits Disappointing Results
Dimensions of Dental Hygiene
JANUARY 19, 2021
Preliminary data on the CoronaVac—a COVID-19 vaccination manufactured by the Beijing-based biopharmaceutical company Sinovac—demonstrated only about 50% efficacy in preventing mild and severe COVID-19 illness in a Brazilian clinical trial. Click here to read more.
Let's personalize your content